期刊文献+

注射用丹参多酚酸盐联合替格瑞洛治疗不稳定型心绞痛患者疗效观察 被引量:4

下载PDF
导出
摘要 目的:研究注射用丹参多酚酸盐联合替格瑞洛治疗不稳定型心绞痛(UAP)患者的临床疗效。方法:选取我院所收治的68例UAP患者,按照随机抽签法分为对照组和观察组,每组34例,对照组采用替格瑞洛治疗,观察组采用注射用丹参多酚酸盐联合替格瑞洛治疗,治疗后观察两组的心绞痛持续时间、发作次数,心电图改善疗效和临床疗效。结果:治疗后观察组与对照组相比,心绞痛持续时间缩短、发作次数减少(P<0.05);治疗后观察组心电图改善疗效及临床疗效高于对照组(P<0.05)。结论:注射用丹参多酚酸盐联合替格瑞洛治疗UAP患者,能有效缩短心绞痛发作持续时间,减少心绞痛发作次数,改善患者心电图和临床疗效。
出处 《医学理论与实践》 2019年第21期3440-3441,共2页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献5

二级参考文献42

  • 1张知新,高福云,李克明,潘琳,董晞,陈玉武,孙瑞娟.丹参酚酸B镁对自由基损伤人主动脉内皮细胞的影响[J].中国中西医结合杂志,2004,24(6):521-524. 被引量:26
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2136
  • 3无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3680
  • 4Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study I J]. Lancet, 2001, 358 (9281) : 527-533.
  • 5Sibbing D, Stegherr J, Latz W, et al. Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention[ J]. Eur Heart J, 2009, 30 (8) : 916-922.
  • 6Cheng JW. Ticagrelor: oral reversible P2Y (12) receptor antagonist for the management of acute coronary syndromes [J]. Clin Ther, 2012, 34 (6) : 1 209-220.
  • 7Sabatine MS, Cannon CP, Gibson CM, et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study[ J ]. JAMA, 2005, 294 (10): 1 224-232.
  • 8Steinhubl SR, Berger PB, Mann JR, et al. Early and sustained dual oral antiplatelet therapy foUowing percutaneous coronary intervention: a randomized controlled trim [ J ]. JAMA, 2002, 288 (19): 2411-420.
  • 9Gurbel PA, Bliden KP, Hayes KM, et al. The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting [ J ]. J Am Coil Cardiol, 2005, 45 (9) : 1 392-396.
  • 10Ferri N, Corsini A, Bellosta S. Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties [ J ]. Drugs, 2013, 73 (15) : 1 681-709.

共引文献81

同被引文献22

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部